Laia Chavarria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laia Chavarria has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Juan Córdoba
Hospital Vall Hebrón
6 shared publications Juli Alonso
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
5 shared publicationsAlex Rovira
Magnetic Resonance Unit (IDI), Department of Radiology, Hospital d'Vall Hebron, Barcelona, Spain
4 shared publications- Marc Oria
Department of Radiation Oncology, University of Cincinnati College of Medicine
3 shared publications - Rita García-Martínez
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain
3 shared publications J. Cordoba
2 shared publications
Latest Publications
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S338-S339
P0102 : Degeneration signs of Purkinje neurons in a new animal model of episodic hepatic encephalopathy
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S338-S339
P0102 : Degeneration signs of Purkinje neurons in a new animal model of episodic hepatic encephalopathy
- 1 March 2015
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 5, S69-S74
Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy
- 1 March 2015
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 5, S69-S74
Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy
- 10 October 2014
- Published by Wiley in NMR in Biomedicine
- Vol. 28 (1) , 17-23
Real‐time assessment of 13C metabolism reveals an early lactate increase in the brain of rats with acute liver failure
Intracranial hypertension is a severe complication of acute liver failure (ALF) secondary to brain edema. The pathogenesis of cerebral edema in ALF is not clear, but seems to be related to energy metabolism in which lactate may have an important role. The aim of this study was to follow the synthesis of brain lactate using a novel in vivo metabolic technology in a rat model of ALF. Time‐resolved 13C MRS of hyperpolarized 13C1‐pyruvate was used to quantitatively follow the in vivo conversion of pyruvate to its substrates in a model of devascularized ALF in rats. Rats with ALF showed a significant increase in the lactate to pyruvate ratio from 36% to 69% during the progression of liver disease relative to rats with portocaval anastomosis. Rats with ALF also showed a significant increase in the alanine to pyruvate ratio from 72% to 95%. These increases were detectable at very early stages (6 h) when animals had no evident disease signs in their behavior (without loss of righting or corneal reflexes). This study shows the dynamic consequences of cerebral in vivo 13C metabolism at real time in rats with ALF. The early detection of the de novo synthesis of lactate suggests that brain lactate is involved in the physiopathology of ALF. Hyperpolarization is a potential non‐invasive technique to follow the in vivo metabolism, and both the development and optimization of 13C‐labeled substrates can clarify the mechanism involved in ALF. Copyright © 2014 John Wiley & Sons, Ltd.
- 10 October 2014
- Published by Wiley in NMR in Biomedicine
- Vol. 28 (1) , 17-23
Real‐time assessment of 13C metabolism reveals an early lactate increase in the brain of rats with acute liver failure
Intracranial hypertension is a severe complication of acute liver failure (ALF) secondary to brain edema. The pathogenesis of cerebral edema in ALF is not clear, but seems to be related to energy metabolism in which lactate may have an important role. The aim of this study was to follow the synthesis of brain lactate using a novel in vivo metabolic technology in a rat model of ALF. Time‐resolved 13C MRS of hyperpolarized 13C1‐pyruvate was used to quantitatively follow the in vivo conversion of pyruvate to its substrates in a model of devascularized ALF in rats. Rats with ALF showed a significant increase in the lactate to pyruvate ratio from 36% to 69% during the progression of liver disease relative to rats with portocaval anastomosis. Rats with ALF also showed a significant increase in the alanine to pyruvate ratio from 72% to 95%. These increases were detectable at very early stages (6 h) when animals had no evident disease signs in their behavior (without loss of righting or corneal reflexes). This study shows the dynamic consequences of cerebral in vivo 13C metabolism at real time in rats with ALF. The early detection of the de novo synthesis of lactate suggests that brain lactate is involved in the physiopathology of ALF. Hyperpolarization is a potential non‐invasive technique to follow the in vivo metabolism, and both the development and optimization of 13C‐labeled substrates can clarify the mechanism involved in ALF. Copyright © 2014 John Wiley & Sons, Ltd.
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S71-S72
P16 ‘IN VIVO’ MAGNETIC RESONANCE SPECTROSCOPY WITH HYPERPOLARIZED PYRUVATE EARLY DETECTS LACTATE FORMATION IN ALF RATS
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S71-S72
P16 ‘IN VIVO’ MAGNETIC RESONANCE SPECTROSCOPY WITH HYPERPOLARIZED PYRUVATE EARLY DETECTS LACTATE FORMATION IN ALF RATS
- 21 November 2013
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 29 (4) , 937-944
Magnetic resonance of the brain in chronic and acute liver failure
Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging methods allow a non-invasive assessment of brain alterations in liver failure. Magnetic resonance has gained more interest due to the ability of giving information about cerebral metabolism using spectroscopy, water distribution by diffusion methods or neuronal connectivity by means of resting state magnetic resonance. These techniques have been applied to experimental models and patients with liver failure to elucidate cerebral pathways involved in the pathogenesis of hepatic encephalopathy. In the future, the development of new magnetic resonance implementations will generate handy tools for the study of the brain and get better understanding of the mechanisms that take place in liver failure. This could be useful for the early diagnosis, as well as for the design of new treatments for cerebral complications of liver failure.
- 21 November 2013
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 29 (4) , 937-944
Magnetic resonance of the brain in chronic and acute liver failure
Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging methods allow a non-invasive assessment of brain alterations in liver failure. Magnetic resonance has gained more interest due to the ability of giving information about cerebral metabolism using spectroscopy, water distribution by diffusion methods or neuronal connectivity by means of resting state magnetic resonance. These techniques have been applied to experimental models and patients with liver failure to elucidate cerebral pathways involved in the pathogenesis of hepatic encephalopathy. In the future, the development of new magnetic resonance implementations will generate handy tools for the study of the brain and get better understanding of the mechanisms that take place in liver failure. This could be useful for the early diagnosis, as well as for the design of new treatments for cerebral complications of liver failure.
- Open Access
- 21 November 2012
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 33 (2) , 272-277
Brain Magnetic Resonance Spectroscopy in Episodic Hepatic Encephalopathy
Brain magnetic resonance (MR) study has shown metabolic abnormalities and changes in water distribution of the brain tissue that may relate to the pathogenesis of hepatic encephalopathy (HE). We designed a study to investigate the disturbances in brain water and metabolites during episodic HE using a 3-T MR scanner. Cirrhotic patients with different grades of HE underwent MR during hospitalization ( n = 18). The MR was repeated at 6 weeks' follow-up ( n = 14). The results were compared with those of a group of healthy volunteers ( n = 8). During episodic HE, brain diffusion-weighted imaging showed a high apparent diffusion coefficient (ADC) (12% to 14%) that decreased during follow-up (–1% to −4%). These disturbances were accompanied by high glutamine (581%), low choline (–31%), and low myo-inositol (–86%) peaks on MR spectroscopy. In overt HE, patients showed high glutamine that decreased during follow-up (–22%). In addition, these patients exhibited a rise in plasma S100 beta and enlargement of brain white-matter lesions. In conclusion, several disturbances detected by MR support the presence of impaired brain water homeostasis during episodic HE. Although astrocytes have a major role in this condition, brain edema during episodic HE may be extracellular and does not appear to be directly responsible for the development of neurologic manifestations.
- 21 November 2012
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 33 (2) , 272-277
Open AccessBrain Magnetic Resonance Spectroscopy in Episodic Hepatic Encephalopathy
Brain magnetic resonance (MR) study has shown metabolic abnormalities and changes in water distribution of the brain tissue that may relate to the pathogenesis of hepatic encephalopathy (HE). We designed a study to investigate the disturbances in brain water and metabolites during episodic HE using a 3-T MR scanner. Cirrhotic patients with different grades of HE underwent MR during hospitalization ( n = 18). The MR was repeated at 6 weeks' follow-up ( n = 14). The results were compared with those of a group of healthy volunteers ( n = 8). During episodic HE, brain diffusion-weighted imaging showed a high apparent diffusion coefficient (ADC) (12% to 14%) that decreased during follow-up (–1% to −4%). These disturbances were accompanied by high glutamine (581%), low choline (–31%), and low myo-inositol (–86%) peaks on MR spectroscopy. In overt HE, patients showed high glutamine that decreased during follow-up (–22%). In addition, these patients exhibited a rise in plasma S100 beta and enlargement of brain white-matter lesions. In conclusion, several disturbances detected by MR support the presence of impaired brain water homeostasis during episodic HE. Although astrocytes have a major role in this condition, brain edema during episodic HE may be extracellular and does not appear to be directly responsible for the development of neurologic manifestations.
- 16 November 2012
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 28 (2) , 285-292
Encephalopathy and liver transplantation
Liver transplantation (LT) candidates experience frequently episodic or persistent hepatic encephalopathy. In addition, these patients can exhibit neurological comorbidities that contribute to cognitive impairment in the pre-transplant period. Assessment of the respective contribution of hepatic encephalopathy or comorbidities in the cognitive manifestations is critical to estimate the neurological benefits of restoring liver function. Magnetic resonance imaging and spectroscopy are useful to assess the impact of liver failure or comorbidities. This assessment is critical to decide liver transplant in difficult cases. In the early postoperative period, LT is commonly complicated by a confusional syndrome. The possible role of persisting hepatic encephalopathy in its development has not been clearly established. The origin is usually considered multifactorial and relates to complications following LT, such as infections, rejection, primary liver dysfunction, immunosuppressors, etc.… The diagnosis and treatment is based in the recognition of comorbidities and optimal care of metabolic disturbances. Several studies have demonstrated recovery of cognitive function after LT in patients that have exhibited hepatic encephalopathy. However, some deficits may persist specifically among patients with persistent HE. Other factors present before LT that contribute to a worse neuropsychological outcome after LT are diabetes mellitus and alcohol consumption. Long-term after LT, cognitive function may worsen in relation to vascular risk factors.
- 16 November 2012
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 28 (2) , 285-292
Encephalopathy and liver transplantation
Liver transplantation (LT) candidates experience frequently episodic or persistent hepatic encephalopathy. In addition, these patients can exhibit neurological comorbidities that contribute to cognitive impairment in the pre-transplant period. Assessment of the respective contribution of hepatic encephalopathy or comorbidities in the cognitive manifestations is critical to estimate the neurological benefits of restoring liver function. Magnetic resonance imaging and spectroscopy are useful to assess the impact of liver failure or comorbidities. This assessment is critical to decide liver transplant in difficult cases. In the early postoperative period, LT is commonly complicated by a confusional syndrome. The possible role of persisting hepatic encephalopathy in its development has not been clearly established. The origin is usually considered multifactorial and relates to complications following LT, such as infections, rejection, primary liver dysfunction, immunosuppressors, etc.… The diagnosis and treatment is based in the recognition of comorbidities and optimal care of metabolic disturbances. Several studies have demonstrated recovery of cognitive function after LT in patients that have exhibited hepatic encephalopathy. However, some deficits may persist specifically among patients with persistent HE. Other factors present before LT that contribute to a worse neuropsychological outcome after LT are diabetes mellitus and alcohol consumption. Long-term after LT, cognitive function may worsen in relation to vascular risk factors.
- 26 October 2012
- Published by Wiley in Liver International
- Vol. 33 (2) , 294-300
Brain magnetic resonance in experimental acute‐on‐chronic liver failure
Background & Aim: Acute‐on‐chronic liver failure is the term that refers to sustained liver injury with acute decompensation, usually induced by a precipitating factor. A common link between ensuing failures of various organs is impairment of the vascular supply, which may also induce vasogenic oedema in the brain. The aim of this study was to perform magnetic resonance (MR) study of the brain in a rat model combining bile duct ligation (BDL) and lipopolysaccharide (LPS) administration to investigate brain oedema in liver failure.Methods: Bile duct‐ligated rats underwent in vivo brain MR imaging at 4, 5 and 6 weeks, and after superimposed administration of LPS. The MR techniques applied enabled assessment of brain metabolites, and intra‐ or extracellular water distribution. Brain water content was assessed by gravimetry.Results: MR spectroscopy showed an increase in brain glutamine and a decrease in myo‐inositol and choline in relation to progression of liver disease. BDL rats showed a slight, progressive increase in the amount of cortical brain water that was significant after LPS injection. These changes did not modify the apparent diffusion coefficient, supporting a mixed origin of brain oedema (vasogenic and cytotoxic).Conclusions: The mechanisms leading to the development of brain oedema in an experimental liver disease model were related to the time course of liver failure and to pro‐inflammatory stimuli. MR findings support the presence of cytotoxic and vasogenic mechanisms in induced brain oedema in BDL rats exposed to LPS.
- 26 October 2012
- Published by Wiley in Liver International
- Vol. 33 (2) , 294-300
Brain magnetic resonance in experimental acute‐on‐chronic liver failure
Background & Aim: Acute‐on‐chronic liver failure is the term that refers to sustained liver injury with acute decompensation, usually induced by a precipitating factor. A common link between ensuing failures of various organs is impairment of the vascular supply, which may also induce vasogenic oedema in the brain. The aim of this study was to perform magnetic resonance (MR) study of the brain in a rat model combining bile duct ligation (BDL) and lipopolysaccharide (LPS) administration to investigate brain oedema in liver failure.Methods: Bile duct‐ligated rats underwent in vivo brain MR imaging at 4, 5 and 6 weeks, and after superimposed administration of LPS. The MR techniques applied enabled assessment of brain metabolites, and intra‐ or extracellular water distribution. Brain water content was assessed by gravimetry.Results: MR spectroscopy showed an increase in brain glutamine and a decrease in myo‐inositol and choline in relation to progression of liver disease. BDL rats showed a slight, progressive increase in the amount of cortical brain water that was significant after LPS injection. These changes did not modify the apparent diffusion coefficient, supporting a mixed origin of brain oedema (vasogenic and cytotoxic).Conclusions: The mechanisms leading to the development of brain oedema in an experimental liver disease model were related to the time course of liver failure and to pro‐inflammatory stimuli. MR findings support the presence of cytotoxic and vasogenic mechanisms in induced brain oedema in BDL rats exposed to LPS.
- 1 June 2012
- Published by Elsevier in Neurochemistry International
- Vol. 60 (7) , 684-689
Reprint of: Neuroimaging in acute liver failure
- 1 June 2012
- Published by Elsevier in Neurochemistry International
- Vol. 60 (7) , 684-689
Reprint of: Neuroimaging in acute liver failure
- 1 December 2011
- Published by Elsevier in Neurochemistry International
- Vol. 59 (8) , 1175-1180
Neuroimaging in acute liver failure
- 1 December 2011
- Published by Elsevier in Neurochemistry International
- Vol. 59 (8) , 1175-1180
Neuroimaging in acute liver failure